Reuven Schore

20PUBLICATIONS
72CO-AUTHORS
Haematological tumoursInfant and child healthMedical infection agents (incl. prions)Pacific Peoples youth and familyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 05, 2026
Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group.

|Apr 15, 2026
Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes.

|Jan 05, 2026
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932.

Lyn M Balsamo, John A Kairalla, Emily Hibbitts

|Oct 22, 2025
Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease.

Jason N Berman, Anupam Verma, Shelton Viola

|Sep 20, 2025
Caregivers' Perspectives on Changes in Family Life During B-ALL Therapy: A Qualitative Study From the Children's Oncology Group.

Alexandra Dreyzin, Megan Ware, Katrina Stumbras

|May 13, 2025
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.

Ruth W Wang'ondu, Emily Ashcraft, Ti-Cheng Chang

Pageof 4

Frequent Collaborators

11 joint publications

Mignon Loh

9 joint publications

Naomi J Winick

7 joint publications

Karen R Rabin

7 joint publications

Stephen P Hunger